Over the past several years the options available through multigene hereditary cancer panel testing have exploded. This webinar will focus on some of the most common moderate-risk genetic mutations related to breast and ovarian cancer, testing available to determine your risk, and options available for you if you test positive.

This program is presented by Sharsheret, with partnership support from SHARE.